Effects of cyclic adenosine monophosphate modulating agents during oocyte pre-maturation and the role of melatonin on in vitro maturation of bovine cumulus-oocyte complexes.
Animals
Cattle
Female
Melatonin
/ pharmacology
1-Methyl-3-isobutylxanthine
/ pharmacology
In Vitro Oocyte Maturation Techniques
/ veterinary
Natriuretic Peptide, C-Type
/ pharmacology
Colforsin
/ pharmacology
Oocytes
/ physiology
Cyclic AMP
/ metabolism
RNA, Messenger
/ metabolism
Superoxide Dismutase
/ metabolism
Adenosine Monophosphate
/ metabolism
Cumulus Cells
Antioxidant
Meiotic resumption
Melatonin and cAMP
in vitro pre-maturation
Journal
Animal reproduction science
ISSN: 1873-2232
Titre abrégé: Anim Reprod Sci
Pays: Netherlands
ID NLM: 7807205
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
30
05
2023
revised:
16
08
2023
accepted:
01
09
2023
medline:
13
10
2023
pubmed:
12
9
2023
entrez:
11
9
2023
Statut:
ppublish
Résumé
This study investigated the effects of cyclic adenosine monophosphate modulating during cumulus-oocyte complexes (COCs) pre-maturation and the role of melatonin on in vitro maturation (IVM) of bovine COCs. In experiment one, COCs were pre-matured for 8 h in control medium or with 3-isobutyl-1-methylxanthine (IBMX) and forskolin, IBMX and C-type natriuretic peptide, c-type natriuretic peptide and forskolin or IBMX, forskolin and c-type natriuretic peptide. Then, meiotic progression was evaluated. In experiment two, COCs were pre-matured, followed by IVM in control medium alone or with 10
Identifiants
pubmed: 37696223
pii: S0378-4320(23)00141-0
doi: 10.1016/j.anireprosci.2023.107327
pii:
doi:
Substances chimiques
Melatonin
JL5DK93RCL
1-Methyl-3-isobutylxanthine
TBT296U68M
Natriuretic Peptide, C-Type
127869-51-6
Colforsin
1F7A44V6OU
Cyclic AMP
E0399OZS9N
RNA, Messenger
0
Superoxide Dismutase
EC 1.15.1.1
Adenosine Monophosphate
415SHH325A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107327Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no competing interests.